Skip to main content
Sunita Nathan, MD, Hematology, Chicago, IL

SunitaNathanMD

Hematology • Chicago, IL

Hematologic Oncology, Myeloproliferative Disorder Hematology-Oncology

Associate Professor of Medicine, Rush Medical College of Rush University Associate Director, Section of Bone Marrow Transplant and Cell Therapy Medical Director, Apheresis Program

Request Appointment

Overview of Dr. Nathan

Dr. Sunita Nathan is a hematologist based in Chicago, IL, specializing in hematology with subspecialties in hematologic oncology and myeloproliferative disorder hematology-oncology. She completed her fellowship in hematology and medical oncology and residency in internal medicine at Cook County Health and Hospitals System, after graduating from B.J. Medical College at the University of Pune in 1998. Dr. Nathan has experience with hematopoietic stem cell transplantation and conditions such as acute myeloid leukemia, Hodgkin's lymphoma, multiple myeloma, and lymphoma. She has authored multiple peer-reviewed publications and is involved in clinical trials, including one on blood stem cell transplant for relapsed follicular non-Hodgkin's lymphoma. She has also received the CMS Meaningful Use Stage 1 Certification from EpicCare Ambulatory EMR.

Education & Training

  • Cook County Health and Hospitals System
    Cook County Health and Hospitals SystemFellowship, Hematology and Medical Oncology, 2005 - 2008
  • Cook County Health and Hospitals System
    Cook County Health and Hospitals SystemResidency, Internal Medicine, 2001 - 2004
  • B.J. Medical College - University of Pune
    B.J. Medical College - University of PuneClass of 1998

Certifications & Licensure

  • IL State Medical License
    IL State Medical License 2004 - 2026
  • American Board of Internal Medicine Hematology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013

Clinical Trials

Publications & Presentations

PubMed

Lectures

  • Checkpoint Blockade Therapy May Sensitize Hodgkin Lymphoma to Subsequent Therapy 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
  • Checkpoint Blockade Therapy May Sensitize Aggressive and Indolent Non-Hodgkin Lymphoma to Subsequent Therapy 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Professional Memberships

Insurance Accepted

  • Aetna Choice POS II
    Aetna HMO
    BCBS Blue Card PPO
    BCBS California PowerSelect HMO
    BCBS California PPO
    BCBS Georgia Blue Choice HMO
    BCBS Georgia BlueChoice Option POS
    BCBS Illinois BlueChoice Select
    BCBS Illinois PPO
    CIGNA HMO
    CIGNA Open Access
    CIGNA PPO
    First Health PPO
    Great West PPO
    Humana ChoiceCare Network PPO
    Multiplan PHCS PPO
    Multiplan PPO
    Pacificare HMO
    United Healthcare - Direct Choice Plus POS
    United Healthcare - Direct Options PPO
  • Please verify your coverage with the provider's office directly when scheduling an appointment

Dr. Sunita Nathan, Dr. Sunita Nathan, MD, Dr. S Nathan